rs143965233
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_004817.4(TJP2):c.2992-8C>T variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00208 in 1,613,862 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_004817.4 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TJP2 | NM_004817.4 | c.2992-8C>T | splice_region_variant, intron_variant | ENST00000377245.9 | NP_004808.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TJP2 | ENST00000377245.9 | c.2992-8C>T | splice_region_variant, intron_variant | 1 | NM_004817.4 | ENSP00000366453.4 | ||||
ENSG00000285130 | ENST00000642889.1 | c.3379-8C>T | splice_region_variant, intron_variant | ENSP00000493780.1 |
Frequencies
GnomAD3 genomes AF: 0.00307 AC: 468AN: 152200Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00127 AC: 318AN: 250104Hom.: 0 AF XY: 0.00103 AC XY: 139AN XY: 135428
GnomAD4 exome AF: 0.00198 AC: 2891AN: 1461544Hom.: 3 Cov.: 32 AF XY: 0.00189 AC XY: 1372AN XY: 727108
GnomAD4 genome AF: 0.00308 AC: 469AN: 152318Hom.: 0 Cov.: 32 AF XY: 0.00289 AC XY: 215AN XY: 74488
ClinVar
Submissions by phenotype
not provided Benign:5
Likely benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, University Medical Center Utrecht | - | - - |
Likely benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Feb 01, 2024 | TJP2: BP4 - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Dec 06, 2019 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 19, 2024 | - - |
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jun 18, 2015 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Feb 07, 2013 | 2992-8C>T in intron 20A of TJP2: This variant is not expected to have clinical s ignificance because it has been identified in 0.7% (29/4406) of African American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http ://evs.gs.washington.edu/EVS/; dbSNP rs143965233). - |
Cholestasis, progressive familial intrahepatic, 4;C5542604:Hypercholanemia, familial 1 Benign:1
Benign, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Feb 28, 2022 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at